One and Done: Why People Are Eager for Johnson & Johnson’s Vaccine

The New York Times – Business:

Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.

Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.